NUTEX HEALTH INC (NUTX) Stock Price & Overview

NASDAQ:NUTX • US67079U3068

Current stock price

100.38 USD
+0.89 (+0.89%)
At close:
100.38 USD
0 (0%)
After Hours:

The current stock price of NUTX is 100.38 USD. Today NUTX is up by 0.89%. In the past month the price decreased by -7.46%. In the past year, price increased by 94.23%.

NUTX Key Statistics

52-Week Range45.88 - 193.07
Current NUTX stock price positioned within its 52-week range.
1-Month Range83.99 - 120
Current NUTX stock price positioned within its 1-month range.
Market Cap
699.649M
P/E
11.18
Fwd P/E
4.69
EPS (TTM)
8.98
Dividend Yield
N/A

NUTX Stock Performance

Today
+0.89%
1 Week
+6.72%
1 Month
-7.46%
3 Months
-43.18%
Longer-term
6 Months -2.10%
1 Year +94.23%
2 Years +597.81%
3 Years -33.74%
5 Years N/A
10 Years N/A

NUTX Stock Chart

NUTEX HEALTH INC / NUTX Daily stock chart

NUTX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to NUTX. When comparing the yearly performance of all stocks, NUTX is one of the better performing stocks in the market, outperforming 84.59% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NUTX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to NUTX. While NUTX has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NUTX Earnings

On March 5, 2026 NUTX reported an EPS of 1.61 and a revenue of 151.68M. The company missed EPS expectations (-76.92% surprise) and missed revenue expectations (-42.54% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateMar 5, 2026
PeriodQ4 / 2025
EPS Reported$1.61
Revenue Reported151.679M
EPS Surprise -76.92%
Revenue Surprise -42.54%

NUTX Forecast & Estimates

9 analysts have analysed NUTX and the average price target is 255 USD. This implies a price increase of 154.03% is expected in the next year compared to the current price of 100.38.

For the next year, analysts expect an EPS growth of 138.53% and a revenue growth -5.41% for NUTX


Analysts
Analysts82.22
Price Target255 (154.03%)
EPS Next Y138.53%
Revenue Next Year-5.41%

NUTX Groups

Sector & Classification

NUTX Financial Highlights

Over the last trailing twelve months NUTX reported a non-GAAP Earnings per Share(EPS) of 8.98. The EPS increased by 2.86% compared to the year before.


Income Statements
Revenue(TTM)875.26M
Net Income(TTM)64.21M
Industry RankSector Rank
PM (TTM) 7.34%
ROA 6.99%
ROE 19.49%
Debt/Equity 0.91
Chartmill High Growth Momentum
EPS Q2Q%-85.52%
Sales Q2Q%-41.12%
EPS 1Y (TTM)2.86%
Revenue 1Y (TTM)82.36%

NUTX Ownership

Ownership
Inst Owners38.08%
Shares6.97M
Float4.97M
Ins Owners2.39%
Short Float %18.26%
Short Ratio4.5

About NUTX

Company Profile

NUTX logo image Nutex Health, Inc. engages in the management and operation of healthcare facilities. The company is headquartered in Houston, Texas and currently employs 944 full-time employees. The company went IPO on 2011-03-18. The firm operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

Company Info

IPO: 2011-03-18

NUTEX HEALTH INC

6030 S. Rice Ave., Suite C

Houston TEXAS US

Employees: 944

NUTX Company Website

NUTX Investor Relations

Phone: 13026365400

NUTEX HEALTH INC / NUTX FAQ

What does NUTEX HEALTH INC do?

Nutex Health, Inc. engages in the management and operation of healthcare facilities. The company is headquartered in Houston, Texas and currently employs 944 full-time employees. The company went IPO on 2011-03-18. The firm operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.


Can you provide the latest stock price for NUTEX HEALTH INC?

The current stock price of NUTX is 100.38 USD. The price increased by 0.89% in the last trading session.


Does NUTX stock pay dividends?

NUTX does not pay a dividend.


How is the ChartMill rating for NUTEX HEALTH INC?

NUTX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the analyst forecast for NUTX stock?

9 analysts have analysed NUTX and the average price target is 255 USD. This implies a price increase of 154.03% is expected in the next year compared to the current price of 100.38.


Is NUTEX HEALTH INC (NUTX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NUTX.


What is the next earnings date for NUTX stock?

NUTEX HEALTH INC (NUTX) will report earnings on 2026-05-11.